Russia is facing a sharp growth of drug price these days due to a record inflation and the ever-deteriorating business ...

USA-based CNS specialist MapLight Therapeutics successfully made its public debut on Sunday evening, raising more than $250 ...

UK pharma major GSK and US clinical-stage biotech Empirico, with leading capabilities in human genetics-driven target ...

French pharma major Sanofi this morning revealed that it has successfully priced its offering of $3 billion of notes across 5 tranches: ...

Denmark-based Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for ...

UK pharma major GSK and private French biotech Syndivia company, which is focused on next-generation antibody-drug conjugate ...

US biopharma company Incyte has announced new data from the Phase IIIb TRuE-AD4 study evaluating the efficacy and safety of ...

UK pharma major AstraZeneca’s rare disease unit Alexion today revealed that Koselugo (selumetinib), its oral, selective MEK ...

Henrik Vestergaard, acting chief executive of Lif, the Danish Industry Association, has taken aim at the USA’s ...

Privately-held Californian biopharma Sydnexis has announced that the US Food and Drug Administration (FDA) has issued a ...

Shares of BridgeBio Pharma rose more than 15% to $62.52 in early trading, after the company reported positive top-line ...

Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for humanized anti-soluble aggregated amyloid-beta ...